S

$SLNO

82 articles found
2 positive
80 negative
0 neutral
GlobeNewswire Inc.GlobeNewswire Inc.··Bragar Eagel & Squire, P.C.

Soleno Therapeutics Faces Class Action Over Alleged PWS Drug Safety Misstatements

Class action lawsuit filed against $SLNO alleging false statements about DCCR safety concerns and commercial viability for Prader-Willi syndrome treatment.
SLNOsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Faruqi & Faruqi, Llp

Soleno Therapeutics Faces Securities Fraud Probe Over Undisclosed Safety Data

Law firm probing Soleno Therapeutics for allegedly concealing safety data on drug DCCR. Investors must file claims by May 5, 2026.
SLNOstock declinesecurities class action